Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2008
12/10/2008CN101318007A Traditional Chinese medicine capsule for esophagus cancer and stomach cancer
12/10/2008CN101317997A Preparation for effective component of turmeric
12/10/2008CN101317965A Traditional Chinese medicinal preparation for treating cancer
12/10/2008CN101317909A Externally used drug for treating difficult and complicated pain like tumour and preparation method thereof
12/10/2008CN101317883A Prunella spike active site and application of the same in preparing medicament composition
12/10/2008CN101317869A Method for extracting flavone from capillary wormwood
12/10/2008CN101317852A Powder injection of compound glycyrrhizic acid glycosides and preparation method thereof
12/10/2008CN101317851A Freeze drying prescription containing glycyrrhizin and preparation method thereof
12/10/2008CN101317845A Pharmaceutical use of 6-aryl substituted pyridine compounds
12/10/2008CN101317841A Sugar apple lactone high-efficiency position medicine-Ainuoning, preparation method and application thereof
12/10/2008CN101317837A Effective component of rabdosia, preparation method and application thereof
12/10/2008CN101317836A Application of (3aR,5R,11bR)-3,3a,5,11b-tetrahydro-7-hydroxyl-5-methyl-2H-furo[3,2-b]naphtho[2,3-d]pyran -2,6,11-trione
12/10/2008CN101317835A Application of cantharidin and its derivant in preparing sensitization medicament for tumour chemotherapy
12/10/2008CN101317832A Oral administration nano-drug administration system of resveratrol
12/10/2008CN101317823A Implantation type antineoplastic drug of 10-hydroxycamptothecin dual-sustained-release particle formulation and preparation method thereof
12/10/2008CN101317820A Biological endophilic ligand numerator mediated target liposome, preparation and uses thereof
12/10/2008CN101317818A Methopterin intralipid, its freeze drying agent, preparation method and application thereof
12/10/2008CN101317816A Docetaxel long-circulation formulation
12/10/2008CN101317656A Charge mixture for ginseng soup and preparation thereof
12/10/2008CN100441595C Novel peptides that bind to the erythropoietin receptor
12/10/2008CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
12/10/2008CN100441582C Folid acid derivatives and their salts for preparing antitumor medicine
12/10/2008CN100441581C 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1,2-a]pyrimidin-5(1H)-one derivatives
12/10/2008CN100441223C Human papilloma virus treatment
12/10/2008CN100441222C Application of compound PS-341 in preparation of medicine for treating acute pulp leucocythemia
12/10/2008CN100441221C Method of reducing side effects of chemotherapy in cancer patient
12/10/2008CN100441205C Medicine for treating blood system disease
12/10/2008CN100441197C Medicinal composition containing panax ginseng polysaccharide
12/10/2008CN100441190C Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
12/10/2008CN100441186C Medical use of artificial lywrine
12/10/2008CN100441178C Novel use of effective constituent Nodosin of rabdosia lophanthide
12/10/2008CN100441176C Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
12/10/2008CN100441172C 'Huachan'essence coated micropills and its preparation process
12/10/2008CN100441170C Astragalus root extract chewing tablet and preparation method of astragalus root extract
12/09/2008US7462733 Preparation and use of α-keto phosphonates
12/09/2008US7462713 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
12/09/2008US7462705 Nucleic acids encoding an enediyne polyketide synthase complex
12/09/2008US7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity
12/09/2008US7462691 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers
12/09/2008US7462647 Pentalfluoroalkanesulfinyl naphthalenes and related estrogen receptor modulators
12/09/2008US7462642 Anti-cancer combinations
12/09/2008US7462625 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/09/2008US7462623 Quinazoline derivatives as Src tyrosine kinase inhibitors
12/09/2008US7462621 9-[3-(2-Fluorophenyl)-propyl]-7,7-dimethyl-2-(pyridin-4-yl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; neurodegenerative disease caused by abnormal activity of GSK3 beta (glycogen synthase kinase beta 3) or GSK3 beta and cdk5/p253
12/09/2008US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
12/09/2008US7462614 7-(2-Bromophenyl)-5-methyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine; to treat neoplasms; polo like kinases inhibitors; antineoplastic/antiproliferative agents; cyclization of 1,2,4-triazine derivatives; coupling if imidazo[5,1-f][1,2,4]triazines with amine or halogen derivatives
12/09/2008US7462601 Ameliorant for chemical treatment of cancer
12/09/2008US7462592 Compositions and methods for polynucleotide delivery
12/09/2008US7462465 Nucleic acid encoding KCNB potassium channel
12/09/2008US7462360 for induction of interferon/natural killer cell activity; for treating viral/fungal systemic infections, or oncological diseases
12/09/2008US7462353 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
12/09/2008US7462350 cytokine fusion proteins with an increased therapeutic index; able to bind to more than one type of cytokine receptor expressed on cells
12/09/2008US7462345 Radionuclide labeling of vitamin B12 and coenzymes thereof
12/09/2008CA2425368C New sulphoxybenzamides
12/09/2008CA2388142C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/09/2008CA2385871C Ltb4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
12/09/2008CA2326485C Anticancer compositions
12/09/2008CA2183151C Host-vector system for use in gene therapy
12/04/2008WO2008148057A2 Cationic lipids compositions and methods for enhancing immune responses to vaccines
12/04/2008WO2008148034A1 Mapk/erk kinase inhibitors
12/04/2008WO2008147956A2 Toll-like receptor 3 modulators and uses thereof
12/04/2008WO2008147782A1 Raf inhibitors for the treatment of thyroid cancer
12/04/2008WO2008147405A1 O-glycans in the treatment of inflammatory bowel disease and cancers
12/04/2008WO2008147243A1 Binuclear nirtosyl-iron complexes with benzo-trans-heterocyclic derivatives and a method for the production thereof
12/04/2008WO2008147242A1 Use of a tetra-nitrosyl-iron complex with thiophenol as an antitumoral medicinal agent
12/04/2008WO2008147005A1 Compositions comprising an extract of tiarella polyphylla or compounds isolated therefrom for preventing and treating cancer diseases
12/04/2008WO2008146914A1 Heterocyclic compound
12/04/2008WO2008146911A1 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
12/04/2008WO2008146854A1 Paratope and epitope of anti-mortalin antibody
12/04/2008WO2008146841A1 Nucleic acid carrier for introduction of nucleic acid into cancer cell
12/04/2008WO2008146774A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008WO2008146165A2 Kit of parts for the treatment of cancer or infectious diseases
12/04/2008WO2008146036A1 Combination of checkponit kinase ( chk) and telangiectasia mutated (atm) inhibitors for the treatment of cancer
12/04/2008WO2008146035A1 Combination of chk and parp inhibitors for the treatment of cancers
12/04/2008WO2008146009A1 Plant extract and its therapeutic use
12/04/2008WO2008145842A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008WO2008145678A1 Pyrazolopyrimidinone kinase inhibitor
12/04/2008WO2008145403A1 Processes related to making capecitabine
12/04/2008WO2008145398A1 4-arylpyrrole substituted 2-indoline derivatives active as protein kinase inhibitors
12/04/2008WO2008145338A2 Monoclonal antibodies against claudin-18 for treatment of cancer
12/04/2008WO2008145243A1 Pyridazinone derivatives
12/04/2008WO2008145242A1 Aryl ether pyridazinone derivatives
12/04/2008WO2008145136A1 Stat3 inactivation by inhibition of the folate receptor pathway
12/04/2008WO2008145013A1 Fusion protein comprising targeting peptide of cd13 and lidamycin
12/04/2008WO2008144996A1 Stable pharmaceutical cucurbitacin liquid composition
12/04/2008WO2008144942A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008WO2008144931A1 Compositions and methods for modulating gated ion channels
12/04/2008WO2008144925A1 Iap bir domain binding compounds
12/04/2008WO2008144919A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144889A1 Humanized and chimeric anti-cd59 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008127710A3 Methods for treating cancer resistant to erbb therapeutics
12/04/2008WO2008125800A3 Mmp activated vascular disrupting agents
12/04/2008WO2008120203A3 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
12/04/2008WO2008119771A3 Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
12/04/2008WO2008119741A3 3-imidazolyl-indoles for the treatment of proliferative diseases
12/04/2008WO2008115088A8 Use of rhodamine 6g in the form of a medicinal agent for treating malignant neoplasms and amiloidoses
12/04/2008WO2008109352A3 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
12/04/2008WO2008108647A3 Enhancement of anticancer therapy by flavonoids
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 2211